logo

Alkermes Plc (ALKS)



Trade ALKS now with
  Date
  Headline
4/30/2018 7:07:49 AM Alkermes To Present Clinical Data At Upcoming American Psychiatric Association Annual Meeting
4/26/2018 7:04:08 AM Alkermes Q1 GAAP Net Loss Per Share $0.40; Non-GAAP Loss Per Share $0.09
4/26/2018 7:03:29 AM Alkermes Completes Patient Enrollment In Pivotal Weight Study Of ALKS 3831 For Schizophrenia
4/16/2018 6:51:39 AM Alkermes Says FDA Accepts For Review Of NDA For ALKS 5461 For Adjunctive Treatment Of Major Depressive Disorder
4/2/2018 7:15:51 AM Alkermes Plc Trading Halted; Expected To Resume At 7:30 AM ET
4/2/2018 7:02:07 AM Alkermes Receives Refusal To File Letter From FDA Regarding Its NDA For ALKS 5461
3/1/2018 7:04:21 AM Alkermes Names James Robinson President And COO, Effective March 5